Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-27 Purchase | 2026-08-31 4:10 pm | Veraxa Biotech AG - Post de-SPAC | VRXA | Baumann Oliver Rolf Director | 50,000 | $1.5 | $75,000 | 5,773,618 (Indirect) | View |
| 2026-08-27 Purchase | 2026-08-31 4:10 pm | Veraxa Biotech AG - Post de-SPAC | VRXA | Antz Christoph Rudiger Chief Executive Officer | 5,000 | $1.53 | $7,650 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-06-10 09:28 am | N/A N/A | Veraxa Biotech Holding AG | VRXA | Ziegler Christoph Samuel Director | 0 | $0 | 7,932 (Direct) | View |
Ownership | 2026-06-09 9:58 pm | N/A N/A | Veraxa Biotech Holding AG | VRXA | Hosseinion Warren Director | 0 | $0 | 700,000 (Direct) | View |
Ownership | 2026-06-09 8:04 pm | N/A N/A | Veraxa Biotech Holding AG | VRXA | Baumann Oliver Rolf Director | 0 | $0 | 5,723,618 (Indirect) | View |